Mr. Billington is CEO and Co-Founder at Versant Diagnostics. Previously he was Co-Founder, Board of Directors, and Chief Operating Officer at American Esoteric Laboratories. Prior, he served as Senior Vice President of Operations, Chief Operating Officer, and Board of Directors (ex officio) at AmeriPath. He was Co-Founder, President, and Chief Operating Officer at Inform DX that merged with PATH. He was Vice President of Finance and Chief Financial Officer for the Western Division of LabCorp. Mr. Billington served as an Adjunct Professor of Entrepreneurship at Bradley University between 2013 and 2018 and began his career as a Certified Public Accountant for Coopers & Lybrand.
Mr. Carr is a Board Director and Co-Founder of Versant Diagnostics. He serves on multiple boards, including Igenomix, Protypia, and SBA Communications Corp. Mr. Carr was Co-Founder, Chairman, and CEO of Regional Diagnostic Laboratories; Co-Founder and CEO of OralDNA Labs; and Co-Founder, Chairman, and CEO of American Esoteric Laboratories. Mr. Carr was President and a member of the
Board of Directors at AmeriPath.
Mr. Mraz co-founded Iron Path Capital in 2021, co-leads the firm’s private equity execution and leads Iron Path’s “Full Immersion” program. Prior to founding Iron Path, he was an executive at NuSil Technology, a global leader in specialty materials for healthcare and aerospace. During his tenure as President of NuSil, Mr. Mraz led the team that diversified the company into new segments including electronics, personal care and drug-delivery. Before NuSil, Mr. Mraz was an investment professional at Quad-C and Apax Partners, and previously held investment banking roles at Merrill Lynch and Bank of America. Mr. Mraz holds a B.S. degree in Finance and Accounting from Ithaca College.
Mr. Olan has dedicated the past 28 years to building Dental Care Alliance. DCA is recognized as one of the largest DSO’s in the country with over 375 locations in 22 states. At Dental Care Alliance, Mr. Olan served for 18 years as chief operating officer, chief executive officer for six years, and executive chairman for the past four years. Prior to joining DCA Mr. Olan was Senior Vice President of Optioncare Inc. He began his career at ORMCO Corporation holding various roles in sales and management over a ten-year period. Mr. Olan holds a bachelor’s degree in business administration, obtained from Indiana University’s Kelly School of Business.
Mr. Reistetter co-founded Iron Path Capital in 2021, co-leads the firm’s private equity execution and leads Iron Path’s internal operations. Prior to founding Iron Path, he was a Principal with Quad-C and was one of two senior professionals that established the healthcare vertical at Quad-C. Prior to joining Quad-C, he worked at JLL Partners where he evaluated and executed private equity investments in various industries. Prior to JLL Partners, Mr. Reistetter was with J.P. Morgan Chase in the Leveraged Finance Group. Mr. Reistetter holds a B.S. degree in Finance & Accounting from Ithaca College and an M.B.A. from Harvard Business School.
Mr. Witthoft is a Senior Associate on the investment team at Iron Path Capital, where he supports the identification, evaluation, and execution of investment opportunities in the healthcare services and specialty industrial manufacturing sectors. Prior to joining Iron Path, he worked at Ernst & Young in the Decision Modeling & Economics group, where he supported clients with complex analytical modeling for mergers & acquisitions, investment management, and strategic operational initiatives in a variety of industries. Mr. Witthoft holds a B.B.A. degree in Finance and Management Information Systems from the University of Georgia.